Layer: L4-IDM-Auto
Date: 2026-05-28
Analyst: Claude (claude-sonnet-4-6)
Satellite context: EUR ~3,000 available; existing holdings AGN.AS / RI.PA / AIG / AKE.PA
| Metric | Value |
|---|---|
| Current Price | JPY 4,306 (EUR 23.21 @ 185.53 JPY/EUR) |
| 52w High | JPY 4,689 |
| 52w Low | JPY 1,656 |
| Distance from 52w High | -8.2% |
| YTD Return | +93.5% |
| 1Y Return | +150% (from JPY 1,720 one year ago) |
| 2Y Return | +49% (from JPY 2,891 two years ago) |
| Previous Close | JPY 4,474 |
SCREEN DECISION: ABBREVIATED — YTD +93.5% > 80% threshold AND within 10% of 52w high (-8.2%).
The stock has already repriced dramatically. The central question — "auto cycle keeping it depressed?" — is answered NO. The auto cycle discount has been fully unwound and then some.
The stock traded at JPY 1,656 at its 52w low and is now at JPY 4,306 — a 160% move from trough. The "depressed auto IDM" thesis was valid at the lows. It is no longer valid at current prices.
The current price exceeds the mean analyst target. The market has already priced in the recovery.
Q1 2026 results (reported April 24, 2026):
| Metric | Q1 2026 | YoY |
|---|---|---|
| Revenue (GAAP) | JPY 380.3B | +23.2% |
| Revenue (Non-GAAP) | JPY 372.3B | +20.6% |
| Gross Margin (Non-GAAP) | 59.2% | +1.1pp vs guidance |
| Operating Margin (Non-GAAP) | 33.5% | +2.5pp vs guidance |
| EBITDA (Non-GAAP) | JPY 146.2B | +41.3% YoY |
Q2 2026 guidance (Non-GAAP): Revenue JPY 388.0B (+19.5% YoY). H1 2026 guided: JPY 752.8-767.8B (+18.9-21.2% YoY).
Key CEO quote: "Supply is what's constraining growth right now" — demand is strong, supply (testers, wafer capacity) is the limit. This is a high-quality constraint that validates the thesis, but it also means consensus estimates reflect strong execution. The upside surprise potential has already landed in the price.
| Filter | Threshold | Actual | Result |
|---|---|---|---|
| 1. Adequate size | Revenue > USD 100M | USD ~9.1B | PASS |
| 2. Financial condition | CR ≥ 2x; LT debt ≤ current assets | CR 1.17x; LT debt JPY 964B >> CA JPY 724B | FAIL |
| 3. EPS stability | Positive 10 consecutive years | 2025: -28.65 (loss); 4yr window available | FAIL |
| 4. Dividend record | Uninterrupted 20 years | Dividend reinstated ~2016; ~10yr history | FAIL |
| 5. EPS growth | +33% over 10 years | Trailing 2025 loss; but 2022–2024 strong | FAIL |
| 6. Moderate P/E | ≤ 15x trailing | Trailing N/A (loss year); fwd 16.7x | FAIL |
| 7. Moderate P/B | ≤ 1.5x OR P/E×P/B ≤ 22.5 | P/B 3.07x; P/E×P/B ~51x | FAIL |
Graham Score: 1/7 — DEEP FAIL
shr-017 context: This is not a cyclical trap situation (where trailing metrics look good but forward is deteriorating — the NXP/Maersk scenario). This is structurally the opposite: Renesas fails Graham filters on both trailing (loss year 2025) AND absolute valuation (P/B 3.07x, fwd P/E 16.7x). Post-Altium acquisition, the balance sheet carries JPY 1,206B debt against JPY 2,448B equity with a net debt position of JPY 910B. Not a defensive value candidate.
FY2025 net loss was JPY 51.8B despite strong operating cash flow of JPY 452.9B. The disconnect:
The operating margin halving from 26-28% (2022-2023) to 15-16% (2024-2025) is the real concern — this is structural compression from the M&A spree (Dialog, IDT, Celeno, Altium), not just a cyclical dip.
Trailing EPS 2025: JPY -28.65 — Graham IV INVALID (loss year)
Forward EPS 2026E (consensus): JPY 257.36
| Growth Rate | Graham IV (JPY) | vs Current (JPY 4,306) | Margin of Safety |
|---|---|---|---|
| g = 0% | 2,188 | -49.2% | N/A (stock above IV) |
| g = 3% | 3,732 | -13.3% | N/A (stock above IV) |
| g = 5% | 4,761 | +10.6% | +10.6% |
| g = 7.5% | 6,048 | +40.5% | +40.5% |
| g = 10% | 7,335 | +70.3% | +70.3% |
Graham implied growth from fwd P/E 16.7x: (16.7 - 8.5) / 2 = 4.1%
At JPY 4,306, the market is pricing in ~4% sustained earnings growth. For a company in semiconductor auto/industrial with AI/data center optionality and a recovering demand cycle, 4% is arguably conservative — but this is the key tension:
Trailing vs Forward comparison (shr-003): Trailing EPS is a loss. Forward EPS of JPY 257 represents a massive jump — the market is pricing a complete profitability inflection. This is an earnings recovery story, not a value story. The question is not "is it cheap?" but "will the recovery sustain?"
Auto MCU positioning vs Infineon/NXP:
Altium acquisition (completed Aug 2024, USD 5.9B):
Prior acquisitions (Dialog/IDT/Celeno):
China auto exposure:
The broader Japanese equity market (Nikkei, TOPIX) has been bid up significantly since 2023. Key drivers:
Renesas is not a beneficiary of Japan's corporate governance reforms in the same way as trading companies or banking conglomerates. It's an operationally complex serial acquirer — the governance reform narrative doesn't directly apply.
| Year | Operating CF (B JPY) | FCF (B JPY) | Net Debt (B JPY) |
|---|---|---|---|
| 2022 | 479 | 391 | 420 |
| 2023 | 497 | 368 | 216 |
| 2024 | 341 | 171 | 1,037 |
| 2025 | 453 | 319 | 911 |
The FCF trajectory is notable: JPY 391B → 368B → 171B → 319B. The 2024 dip was the Altium acquisition year (capital deployed). Net debt jumped from JPY 216B (2023) to JPY 1,037B (2024) from the Altium deal, then improved slightly to JPY 911B in 2025.
Net Debt / EBITDA (2025): JPY 911B / JPY 404B = 2.25x — manageable but elevated for a cyclical company. FCF yield at current market cap (JPY 7.81T): JPY 319B / JPY 7,810B = 4.1% — decent but not exceptional given the cyclical earnings base.
Since the abbreviated trigger fires (YTD >80%, within 10% of high), no full pre-buy diligence is warranted. This is a WATCH-NOT-BUY situation. Key flags if reconsidering at lower prices:
| Category | Status |
|---|---|
| Price vs thesis | RED — stock has already repriced the recovery thesis |
| Valuation vs peers | AMBER — fwd P/E 16.7x is cheapest among auto IDM peers (Infineon 31x, NXP 19x) but P/B 3.07x not cheap |
| Balance sheet | AMBER — net debt 2.25x EBITDA; post-Altium debt load is manageable but constraining |
| Earnings quality | AMBER — 2025 loss was non-cash impairment; OCF positive throughout |
| Competitive position | AMBER — strong R-Car Gen4 momentum; but China localization is structural risk |
| Analyst sentiment | RED — current price ABOVE consensus mean target (JPY 4,306 vs JPY 3,489 target) |
| M&A integration risk | RED — Altium USD 5.9B deal, no synergy reporting, Wolfspeed impairment precedent |
| Japan FX headwind | AMBER — yen strengthening (Q2 guidance at 156/USD vs 166/USD in Q1) |
Active red flag count: 3 RED + 4 AMBER = do not initiate
Using Graham IV growth framework (shr-018 EV/EUR approach):
At fwd P/E 16.7x and the Graham-implied growth rate of 4.1%, Renesas is fairly valued for slow growth. To beat VWCE (assume ~7% annual return), Renesas needs:
This is achievable over 5 years but is priced in at JPY 4,306. There is no meaningful margin of safety. VWCE already holds some Renesas exposure via MSCI Japan weightings; adding a concentrated position at current price would be doubling down on an already-repriced name.
VERDICT LINE: 🔴 DO NOT BUY — ABBREVIATED (stock fully repriced, above analyst consensus)
Rationale:
Price: YTD +93.5%, within 8.2% of 52w high, current price JPY 4,306 exceeds mean analyst consensus JPY 3,489 by +23%. The thesis ("auto cycle keeping it depressed") is fully unwound.
Graham screen: 1/7 — structural fail. P/B 3.07x, P/E×P/B ~51x, loss year 2025, elevated debt post-Altium (net debt 2.25x EBITDA). Not a value candidate.
Graham IV: Stock requires 5%+ sustained growth to be fairly valued. At g=3% it's 13% overvalued. The market is pricing in full recovery of an earnings inflection story — no margin of safety for a Graham defensive investor.
Competitive risk: Renesas is a legitimate auto MCU franchise (#5 globally) but is outgunned by Infineon and NXP in the BEV/SoC transition. CEO acknowledged European competitors have better discrete power portfolios for EVs. China localization is a structural headwind not yet visible in numbers.
Altium risk: USD 5.9B for a USD 263M revenue EDA software business is a leveraged bet on software/hardware convergence with no confirmed synergies disclosed. The Wolfspeed impairment (JPY 235B) in 2025 signals this management team has a history of overpaying; Altium goodwill is at elevated risk.
Better alternatives: With EUR 3,000 available and existing positions in AKE.PA (specialty chemicals cyclical recovery at P/B 0.77x), AIG (insurance turnaround), and AGN.AS (financial services at trough), deploying into a semiconductor name at 3.07x book and above analyst consensus would rank poorly on the shr-018 EV/EUR framework.
Re-evaluation trigger: If 6723.T corrects 30-40% from current levels (to JPY 2,600-3,000 range), re-run the screen. At JPY 2,600, fwd P/E drops to ~10x and P/B to ~1.9x — still not cheap on Graham standards but worthy of growth addendum analysis (shr-004). The auto MCU secular story (300 chips/EV vs 70/ICE) is genuinely compelling; the current entry price just does not reflect any margin of safety.
Data sources: yfinance (price, financials, balance sheet, cashflow); Renesas Q1 2026 earnings call transcript (Investing.com); Renesas FY2025 annual report summary; S&P Global / Mordor Intelligence (auto MCU market share); analyst consensus from yfinance (13 analysts)
Screened: 2026-05-28